Pharma Co. Inks $7M Deal To End Investor's Cancer Study Suit
By Emilie Ruscoe · June 2, 2026, 5:42 PM EDT
A Spectrum Pharmaceuticals Inc. investor has asked a New York federal court to approve a $7 million deal resolving class action claims alleging the drugmaker overstated its regulatory prospects for winning...
To view the full article, register now.